Clinical Trial Update: Management of Intracerebral Hemorrhage With Aminocaproic Acid - Pilot Study [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating aminocaproic acid for intracerebral hemorrhage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Amicar (aminocaproic acid)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Intracerebral Hemorrhage | Phase 1 | Status: WITHDRAWN